SC 13G Filing

Company

BioLineRx Ltd.

Filed

March 16, 2015

Accession Number

0000919574-15-002950

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →